The production and evaluation of a radioligand and antiserum for the radioimmunoassay of subnanogram per millilitre concentrations of lamivudine.
Wring
S A
SA
Division of Drug Metabolism, Glaxo Research and Development, Ware, Hertfordshire, UK.
O'Neill
R M
RM
Williams
J L
JL
Jenner
W N
WN
Daniel
M J
MJ
Gray
M R
MR
Newman
J J
JJ
Wells
G N
GN
Sutherland
D R
DR
D000818:Animals; D003429:Cross Reactions; D007106:Immune Sera / Q000096:biosynthesis* / Q000276:immunology; D019259:Lamivudine; D008024:Ligands; D013058:Mass Spectrometry; D009711:Nucleotides / Q000276:immunology; D011863:Radioimmunoassay; D012680:Sensitivity and Specificity; D012756:Sheep; D016047:Zalcitabine / Q000031:analogs & derivatives* / Q000032:analysis / Q000138:chemical synthesis / Q000276:immunology
D007106:Immune Sera; D008024:Ligands; D009711:Nucleotides; D019259:Lamivudine; D016047:Zalcitabine